<DOC>
	<DOCNO>NCT01532453</DOCNO>
	<brief_summary>The purpose trial investigate prevention actinic keratoses squamous cell carcinomas local application MD-3511356 comparison standard sun protection measure immunosuppressed solid organ transplant recipient .</brief_summary>
	<brief_title>Prevention UV-induced Carcinogenic Skin Alterations Immunosuppressed Solid Organ Transplanted Patients</brief_title>
	<detailed_description>This open-label multicenter , randomize , inter-individual comparative , prospective clinical trial design evaluate efficacy safety MD 3511356 sunscreen prevent AK SCC post transplant immune-suppressed patient compare standard care . The present multicenter trial intend contribute evidence daily sun protection prophylactic effect high risk population chronically immune compromised patient .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>OutPatients either sex age â‰¥ 40 year Lifeexpectancy 2 year minimum Solid organtransplant recipient receive kidney ( include pancreas ) , liver , lung , heart transplant Patients treat 5 year immunosuppressant medication Severe sun damage skin Multiple actinic keratoses ( 25 lesion ) and/or multiple dysplastic naevi No present squamous cell carcinoma , basal cell carcinoma malignant melanoma ; history cutaneous/cutaneous invasive malignancy restitutio ad integrum allow Patients able understand provide write informed consent participate clinical trial ( sign inform consent ) accord ICH GCP NonCaucasian Absence sun damage i.e . sign AK Multiorgan transplantation ( exception : simultaneous transplantation kidney pancreas ) Evidence systemic infection , except viral hepatitis , time recruitment Known suppose systemic malignant tumour systemic chemotherapy within last 5 year prior randomisation Patients participate clinical trial within last four week trial Patients treat antitumour/antiangiogenetic immunosuppressant sirolimus , respectively everolimus , acitretin systemic treatment AK time randomisation Patients treat topical drug AK time randomisation ( exception : excision Cryotherapy hyperkeratotic lesion allow ) Change immunosuppressiontreatment less 3 month ago plan Present plan interferon therapy ( liver transplant patient hepatitis B/C ) Female patient childbearing potential positive pregnancy test , breast feeding , female patient childbearing potential without adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>